Skip to main navigation
Fulcrum Therapeutics logo
Menu Button

Main Menu

  • About
  • Our Approach
  • Pipeline
    • Publications
  • Therapeutic Focus
    • FSHD
    • SCD
    • Beta-thalassemia
  • Careers
    • Current Openings
    • Faces of Fulcrum
  • Investor Relations
    • News Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
  • Contact

Corporate Governance

Corporate Governance

Committee Charters
Audit Committee Charter
Science and Technology Committee Charter
Compensation & Human Capital Management Committee
Nominating and Corporate Governance Committee Charter
Governance Documents
Code of Business Conduct & Ethics
Corporate Governance Guidelines

Committee Composition

Audit Committee Compensation & Human Capital Management Committee Nominating and Corporate Governance Committee Science and Technology Committee
Sonja Banks Nominating and Corporate Governance Committee
Katina Dorton Audit Committee Compensation & Human Capital Management Committee
Alan Ezekowitz, MBChB, D.Phil Compensation & Human Capital Management Committee Science and Technology Committee
James Geraghty Audit Committee Nominating and Corporate Governance Committee
Robert J. Gould, Ph.D. Science and Technology Committee
Kate Haviland Audit Committee Nominating and Corporate Governance Committee
Colin Hill Science and Technology Committee
Rachel King Compensation & Human Capital Management Committee
= Chairperson = Member = Chairman of the Board

Investor Tools

Print
Email Page
Email Alerts
IR Contact
Code of Conduct & Business Ethics
Privacy Policy | EU Privacy Policy | Terms of use
Fulcrum TX
Social Media Guidelines

Main Menu

  • About
  • Our Approach
  • Pipeline
    • Publications
  • Therapeutic Focus
    • FSHD
    • SCD
    • Beta-thalassemia
  • Careers
    • Current Openings
    • Faces of Fulcrum
  • Investor Relations
    • News Releases
    • Events and Presentations
    • Stock Information
    • SEC Filings
    • Corporate Governance
    • Investor FAQs
  • Contact